Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MicroRNAs in Postmenopausal Osteoporosis (MIDETE)
NCT03472846Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2017
- Primary completion
- Sep 2022
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab, teriparatide in postmenopausal osteoporosis, sponsored by Medical University of Vienna. Started Mar 2017; status: completed.
02
Drugs
denosumabteriparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT03472846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472846.